US Stock MarketDetailed Quotes

HSCS HeartSciences

Watchlist
  • 2.9100
  • +0.0100+0.34%
Close Mar 21 16:00 ET
  • 3.0500
  • +0.1400+4.81%
Post 20:01 ET
3.15MMarket Cap-0.38P/E (TTM)

HeartSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.89%-1.62M
-120.97%-2.18M
-43.76%-2.02M
-5.14%-6.07M
15.31%-1.58M
-105.97%-2.1M
8.51%-988.19K
22.49%-1.4M
-58.43%-5.77M
-56.14%-1.86M
Net income from continuing operations
-54.29%-2.54M
-19.13%-2.08M
-50.10%-2.05M
-3.95%-6.61M
-13.10%-1.85M
-22.48%-1.64M
3.22%-1.75M
13.12%-1.37M
-31.61%-6.35M
20.49%-1.63M
Operating gains losses
----
----
--10.05K
----
----
----
----
----
----
----
Depreciation and amortization
21.68%28.97K
136.80%34.41K
24.15%33.32K
-29.77%95.13K
-74.03%29.96K
246.76%23.81K
113.28%14.53K
318.53%26.84K
409.87%135.45K
1,675.91%115.36K
Other non cash items
-11.14%109.95K
----
----
310.04%539.23K
-33.92%100K
--123.74K
365.38%215.49K
62.92%100K
-31.41%131.51K
-4.08%151.33K
Change In working capital
203.09%722.47K
-157.87%-245.57K
77.52%-64.95K
-870.66%-504.36K
110.25%60.99K
-323.39%-700.79K
-40.87%424.33K
22.07%-288.89K
-94.18%65.45K
-182.26%-595.19K
-Change in receivables
--0
----
----
--0
--14.7K
---10.8K
----
----
200.00%2.32K
--0
-Change in inventory
-83.34%760
-749.21%-9.87K
---13.86K
2,225.23%47.18K
7,372.55%41.1K
500.13%4.56K
--1.52K
--0
-102.90%-2.22K
417.92%550
-Change in prepaid assets
-74.17%34.99K
-17.85%165.33K
180.93%39.99K
-38.58%236.93K
-143.66%-50.38K
23.17%135.48K
53.65%201.24K
-268.00%-49.41K
431.92%385.77K
56.95%115.39K
-Change in payables and accrued expense
118.54%143.97K
-159.06%-335.22K
35.23%-96.38K
11.18%-241.88K
127.15%115.83K
-482.58%-776.46K
-3.26%567.56K
76.58%-148.8K
-122.24%-272.32K
-163.86%-426.66K
-Change in other current liabilities
-17.40%-26.03K
-1,414.33%-25.26K
-241.10%-24.19K
72.79%-29.53K
---22.84K
---22.17K
---1.67K
--17.15K
---108.54K
----
-Change in other working capital
1,910.90%568.77K
88.09%-40.55K
127.36%29.5K
-955.62%-517.07K
78.74%-37.41K
---31.41K
---340.42K
-145.62%-107.83K
124.53%60.43K
-1,024.81%-175.92K
Cash from discontinued investing activities
Operating cash flow
22.89%-1.62M
-120.97%-2.18M
-43.76%-2.02M
-5.14%-6.07M
15.31%-1.58M
-105.97%-2.1M
8.51%-988.19K
22.49%-1.4M
-58.43%-5.77M
-56.14%-1.86M
Investing cash flow
Cash flow from continuing investing activities
68.08%-15.7K
-199.28%-5.84K
83.03%-833
-584.24%-125.27K
-811.85%-69.23K
-1,317.73%-49.18K
-1.95K
32.25%-4.91K
-847.62%-18.31K
-7.59K
Net PPE purchase and sale
--0
----
----
-252.06%-64.46K
-542.77%-48.8K
-153.50%-8.79K
----
----
-847.62%-18.31K
---7.59K
Net intangibles purchase and sale
61.12%-15.7K
-154.68%-2.69K
83.03%-833
---60.82K
---20.43K
---40.39K
--4.91K
---4.91K
--0
----
Cash from discontinued investing activities
Investing cash flow
68.08%-15.7K
-199.28%-5.84K
83.03%-833
-584.24%-125.27K
-811.85%-69.23K
-1,317.73%-49.18K
---1.95K
32.25%-4.91K
-847.62%-18.31K
---7.59K
Financing cash flow
Cash flow from continuing financing activities
-98.03%180.19K
269.53%1.9M
70.08%551.68K
58.29%10.34M
-76.41%377.14K
7,610.17%9.13M
542.15%514.63K
-93.73%324.36K
70.12%6.53M
104.35%1.6M
Net issuance payments of debt
-41.27%-71.25K
658.73%1.78M
22.97%-52.06K
110.70%42.62K
39.08%-74.04K
58.50%-50.43K
301.63%234.69K
-74.21%-67.59K
-109.42%-398.26K
-115.38%-121.54K
Net common stock issuance
-97.26%251.44K
-56.73%121.12K
54.04%603.75K
83.14%10.3M
5.09%451.18K
--9.18M
--279.94K
-92.45%391.95K
--5.62M
--429.33K
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
--1.31M
--1.29M
Cash from discontinued financing activities
Financing cash flow
-98.03%180.19K
269.53%1.9M
70.08%551.68K
58.29%10.34M
-76.41%377.14K
7,610.17%9.13M
542.15%514.63K
-93.73%324.36K
70.12%6.53M
104.35%1.6M
Net cash flow
Beginning cash position
3,946.29%4.05M
653.89%4.34M
249.76%5.81M
80.83%1.66M
266.48%7.08M
-96.74%100.14K
-85.88%575.65K
129.51%1.66M
26.92%918.26K
45.38%1.93M
Current changes in cash
-120.86%-1.46M
39.51%-287.66K
-35.31%-1.47M
458.76%4.15M
-369.10%-1.27M
709.28%6.98M
60.26%-475.51K
-132.34%-1.08M
281.05%742.21K
34.02%-270.49K
End cash Position
-63.31%2.6M
3,946.29%4.05M
653.89%4.34M
249.76%5.81M
249.76%5.81M
266.48%7.08M
-96.74%100.14K
-85.88%575.65K
80.83%1.66M
80.83%1.66M
Free cash flow
23.92%-1.64M
-121.12%-2.19M
-43.31%-2.02M
-6.97%-6.2M
11.95%-1.65M
-110.08%-2.15M
8.33%-990.14K
22.53%-1.41M
-58.85%-5.79M
-56.78%-1.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.89%-1.62M-120.97%-2.18M-43.76%-2.02M-5.14%-6.07M15.31%-1.58M-105.97%-2.1M8.51%-988.19K22.49%-1.4M-58.43%-5.77M-56.14%-1.86M
Net income from continuing operations -54.29%-2.54M-19.13%-2.08M-50.10%-2.05M-3.95%-6.61M-13.10%-1.85M-22.48%-1.64M3.22%-1.75M13.12%-1.37M-31.61%-6.35M20.49%-1.63M
Operating gains losses ----------10.05K----------------------------
Depreciation and amortization 21.68%28.97K136.80%34.41K24.15%33.32K-29.77%95.13K-74.03%29.96K246.76%23.81K113.28%14.53K318.53%26.84K409.87%135.45K1,675.91%115.36K
Other non cash items -11.14%109.95K--------310.04%539.23K-33.92%100K--123.74K365.38%215.49K62.92%100K-31.41%131.51K-4.08%151.33K
Change In working capital 203.09%722.47K-157.87%-245.57K77.52%-64.95K-870.66%-504.36K110.25%60.99K-323.39%-700.79K-40.87%424.33K22.07%-288.89K-94.18%65.45K-182.26%-595.19K
-Change in receivables --0----------0--14.7K---10.8K--------200.00%2.32K--0
-Change in inventory -83.34%760-749.21%-9.87K---13.86K2,225.23%47.18K7,372.55%41.1K500.13%4.56K--1.52K--0-102.90%-2.22K417.92%550
-Change in prepaid assets -74.17%34.99K-17.85%165.33K180.93%39.99K-38.58%236.93K-143.66%-50.38K23.17%135.48K53.65%201.24K-268.00%-49.41K431.92%385.77K56.95%115.39K
-Change in payables and accrued expense 118.54%143.97K-159.06%-335.22K35.23%-96.38K11.18%-241.88K127.15%115.83K-482.58%-776.46K-3.26%567.56K76.58%-148.8K-122.24%-272.32K-163.86%-426.66K
-Change in other current liabilities -17.40%-26.03K-1,414.33%-25.26K-241.10%-24.19K72.79%-29.53K---22.84K---22.17K---1.67K--17.15K---108.54K----
-Change in other working capital 1,910.90%568.77K88.09%-40.55K127.36%29.5K-955.62%-517.07K78.74%-37.41K---31.41K---340.42K-145.62%-107.83K124.53%60.43K-1,024.81%-175.92K
Cash from discontinued investing activities
Operating cash flow 22.89%-1.62M-120.97%-2.18M-43.76%-2.02M-5.14%-6.07M15.31%-1.58M-105.97%-2.1M8.51%-988.19K22.49%-1.4M-58.43%-5.77M-56.14%-1.86M
Investing cash flow
Cash flow from continuing investing activities 68.08%-15.7K-199.28%-5.84K83.03%-833-584.24%-125.27K-811.85%-69.23K-1,317.73%-49.18K-1.95K32.25%-4.91K-847.62%-18.31K-7.59K
Net PPE purchase and sale --0---------252.06%-64.46K-542.77%-48.8K-153.50%-8.79K---------847.62%-18.31K---7.59K
Net intangibles purchase and sale 61.12%-15.7K-154.68%-2.69K83.03%-833---60.82K---20.43K---40.39K--4.91K---4.91K--0----
Cash from discontinued investing activities
Investing cash flow 68.08%-15.7K-199.28%-5.84K83.03%-833-584.24%-125.27K-811.85%-69.23K-1,317.73%-49.18K---1.95K32.25%-4.91K-847.62%-18.31K---7.59K
Financing cash flow
Cash flow from continuing financing activities -98.03%180.19K269.53%1.9M70.08%551.68K58.29%10.34M-76.41%377.14K7,610.17%9.13M542.15%514.63K-93.73%324.36K70.12%6.53M104.35%1.6M
Net issuance payments of debt -41.27%-71.25K658.73%1.78M22.97%-52.06K110.70%42.62K39.08%-74.04K58.50%-50.43K301.63%234.69K-74.21%-67.59K-109.42%-398.26K-115.38%-121.54K
Net common stock issuance -97.26%251.44K-56.73%121.12K54.04%603.75K83.14%10.3M5.09%451.18K--9.18M--279.94K-92.45%391.95K--5.62M--429.33K
Proceeds from stock option exercised by employees --------------0------------------1.31M--1.29M
Cash from discontinued financing activities
Financing cash flow -98.03%180.19K269.53%1.9M70.08%551.68K58.29%10.34M-76.41%377.14K7,610.17%9.13M542.15%514.63K-93.73%324.36K70.12%6.53M104.35%1.6M
Net cash flow
Beginning cash position 3,946.29%4.05M653.89%4.34M249.76%5.81M80.83%1.66M266.48%7.08M-96.74%100.14K-85.88%575.65K129.51%1.66M26.92%918.26K45.38%1.93M
Current changes in cash -120.86%-1.46M39.51%-287.66K-35.31%-1.47M458.76%4.15M-369.10%-1.27M709.28%6.98M60.26%-475.51K-132.34%-1.08M281.05%742.21K34.02%-270.49K
End cash Position -63.31%2.6M3,946.29%4.05M653.89%4.34M249.76%5.81M249.76%5.81M266.48%7.08M-96.74%100.14K-85.88%575.65K80.83%1.66M80.83%1.66M
Free cash flow 23.92%-1.64M-121.12%-2.19M-43.31%-2.02M-6.97%-6.2M11.95%-1.65M-110.08%-2.15M8.33%-990.14K22.53%-1.41M-58.85%-5.79M-56.78%-1.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
+14.85%
New Fortress Energy
NFE
+7.92%
Cars.com
CARS
+2.11%
Halozyme Therapeutics
HALO
+1.31%
Collegium Pharmaceutical
COLL
+0.40%

Unlock the Full List